FunPep Company Limited AI Stock Analysis
Want to see JP:4881 full AI Analyst Report?
FunPep Company Limited (4881) AI Stock Analysis
FunPep Company Limited
(TSE/TYO:4881)
The stock scores at the minimum due to critical weaknesses across all evaluated areas. Financial performance is dire with accelerating cash burn and no revenue. Technicals show a deep downtrend with oversold but still falling momentum. Negative earnings render valuation metrics ineffective. The company's survival hinges on securing new funding.
FunPep Company Limited (4881) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 2.03B
- Dividend Yield
- ―
- Average Volume (3M)
- 198.91K
- Price to Earnings (P/E)
- -1.1
- Beta (1Y)
- 0.73
- Revenue Growth
- -27.93%
- EPS Growth
- 22.36%
- Country
- Japan
- Employees
- 15
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
FunPep Company Limited Business Overview & Revenue Model
Company Description
FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-...
FunPep Company Limited Financial Statement Overview
Summary
Financial health is extremely weak. Revenue collapsed 94.8% to near zero, net losses deepened to ¥1.9B, and operating cash burn accelerated to ¥1.4B. Equity is eroding rapidly (-42.5% YoY). The only positive is a debt-free balance sheet, but the overall profile signals high risk of requiring urgent capital.
Income Statement
10Very NegativeBalance Sheet
20Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.12M | 314.00K | 6.13M | 530.00K | 1.07M | 126.87M |
| Gross Profit | -20.36M | -41.58M | -37.86M | -43.03M | -12.84M | 125.12M |
| EBITDA | -1.26B | -1.61B | -859.23M | -950.54M | -1.16B | -743.67M |
| Net Income | -1.58B | -1.91B | -889.09M | -933.42M | -1.17B | -682.26M |
Balance Sheet | ||||||
| Total Assets | 2.11B | 1.98B | 3.11B | 2.49B | 2.99B | 3.36B |
| Cash, Cash Equivalents and Short-Term Investments | 1.89B | 1.77B | 2.35B | 1.79B | 2.25B | 3.01B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 433.93M | 516.73M | 566.27M | 192.61M | 298.11M | 188.67M |
| Stockholders Equity | 1.68B | 1.46B | 2.55B | 2.30B | 2.69B | 3.18B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.39B | -537.60M | -989.87M | -1.07B | -892.79M |
| Operating Cash Flow | 0 | -1.39B | -536.74M | -988.82M | -1.05B | -887.47M |
| Investing Cash Flow | 0 | -993.00K | -30.83M | -1.05M | -19.14M | -4.75M |
| Financing Cash Flow | 0 | 810.93M | 1.12B | 537.81M | 245.13M | 282.68M |
FunPep Company Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4881, the sentiment is Negative. The current price of 41.00 is below the 20-day moving average (MA) of 41.35, below the 50-day MA of 46.14, and below the 200-day MA of 66.86, indicating a bearish trend. The MACD of -2.04 indicates Negative momentum. The RSI at 43.82 is Neutral, neither overbought nor oversold. The STOCH value of 43.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4881.
FunPep Company Limited Peers Comparison
Overall Rating
JP:457081Outperform
JP:458752Neutral
JP:218350Neutral
JP:177A45Neutral
JP:457141Neutral- JP:488137Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4570 | 81Outperform | JPY 9.07B | 23.55 | ― | 0.64% | 7.10% | 17.17% |
| JP:4587 | 52Neutral | JPY 139.56B | -38.46 | -7.17% | ― | 14.25% | 50.07% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:2183 | 50Neutral | JPY 4.43B | -1.16 | ― | 4.10% | -21.55% | -497.97% |
| JP:177A | 45Neutral | JPY 3.45B | 27.00 | ― | 1.49% | -9.46% | -82.25% |
| JP:4571 | 41Neutral | JPY 6.56B | -5.20 | -33.61% | ― | 74.24% | -7.78% |
| JP:4881 | 37Underperform | JPY 2.08B | -1.08 | ― | ― | -27.93% | 22.36% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4881 | FunPep Company Limited | 41.00 | -50.00 | -54.95% | |
| JP:4587 | Peptidream | 1081.00 | -550.00 | -33.72% | |
| JP:4571 | NanoCarrier Co., Ltd. | 70.00 | -88.00 | -55.70% | |
| JP:177A | Kohjin Bio Co.,Ltd. | 670.00 | -882.89 | -56.85% | |
| JP:2183 | Linical Co., Ltd. | 195.00 | -142.57 | -42.23% | |
| JP:4570 | Immuno-Biological Laboratories Co., Ltd. | 931.00 | 232.99 | 33.38% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 22, 2026